Posted inTechnology News Cue Health to develop omicron-specific test through HHS partnership – Becker’s Hospital Review Posted by 8 January 2022 … funds to its ongoing partnership with San Diego-based Cue Health, a healthcare technology company, to develop an omicron-genotyping COVID-19 test. View All Posts Post navigation Previous Post Innovative Financing – Grand Challenges CanadaNext PostPalihapitiya SPAC Is Said to Be in Talks With ProKidney – Bloomberg